Related Experiment Videos
[In vitro evaluation of antimicrobial activity of fusafungine]
1Centre d'Etudes Pharmaceutiques, Université de Paris XI, Châtenay-Malabry.
Abstract:
Fusafungine is an antibiotic extracted from the fungus Fusarium laterium WR strain 437. The antimicrobial activity of fusafungine was determined on strains from laboratory collections and clinical isolates; since fusafungine is not soluble in the classical media, the usual techniques had to be modified. MICs for all the Gram-positive cocci and bacteria tested, aerobic, or anaerobic, were below 30 mcg/ml. The antimicrobial activity included Mycoplasma pneumoniae (MIC less than 18 mcg/ml) and Streptococcus mutans (MIC less than 30 mcg/ml). An antifungal activity was shown for most of the Candida albicans tested (MIC less than 32 mcg/ml) and for different Nocardia sp. (MIC less than 13 mcg/ml). Moreover, fusafungine induced neither acquired resistance nor cross-resistance towards the antibiotics classically used in therapy.
Insights
Fusafungine, an antibiotic from Fusarium laterium, shows broad antimicrobial and antifungal activity against various bacteria and fungi. It did not induce acquired or cross-resistance, suggesting potential therapeutic value.
Area of Science:
- Microbiology
- Pharmacology
Background:
- Fusafungine is a novel antibiotic derived from the fungus Fusarium laterium.
- Its unique properties necessitated modifications to standard antimicrobial testing methods.
Purpose of the Study:
- To determine the antimicrobial and antifungal spectrum of fusafungine.
- To evaluate the potential for acquired or cross-resistance to fusafungine.
Main Methods:
- Modified standard microbiological techniques due to fusafungine's insolubility in common media.
- Minimum Inhibitory Concentration (MIC) assays were performed on diverse bacterial and fungal strains, including clinical isolates.
Main Results:
- Fusafungine demonstrated significant activity against Gram-positive cocci and bacteria (aerobic and anaerobic) with MICs below 30 mcg/ml.
- Effective against Mycoplasma pneumoniae (MIC < 18 mcg/ml) and Streptococcus mutans (MIC < 30 mcg/ml).
- Showed antifungal activity against Candida albicans (MIC < 32 mcg/ml) and Nocardia sp. (MIC < 13 mcg/ml).
Conclusions:
- Fusafungine exhibits broad-spectrum antimicrobial and antifungal properties.
- Importantly, fusafungine did not induce acquired resistance or cross-resistance with existing therapeutic antibiotics.